BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer

  June 22, 2026

   · 

  7 min read
• Press Releases

  Bayer and Iambic Collaborate to Advance Drug Discovery with AI

  June 22, 2026

   · 

  4 min read
• Press Releases

  bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

  June 22, 2026

   · 

  7 min read
• 

  Business

  Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in

  About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.

  June 22, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• Press Releases

  Novo Nordisk A/S - share repurchase programme - June 22, 2026

  June 22, 2026

   · 

  2 min read
• Press Releases

  Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer

  June 22, 2026

   · 

  6 min read
• Press Releases

  SeaStar Medical to Present at Upcoming Investor Summit Conference

  June 22, 2026

   · 

  1 min read
• Press Releases

  Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

  June 22, 2026

   · 

  6 min read
• Press Releases

  FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

  June 22, 2026

   · 

  5 min read
• Press Releases

  Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

  June 22, 2026

   · 

  10 min read